군발두통 치료의 최신지견
Update on Treatment of Cluster Headache
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Cluster headache (CH) is characterized by severe unilateral short-lasting headache attacks, accompanying ipsilateral cranial autonomic symptoms or the sense of restlessness and agitation, or both. CH is a highly disabling primary headache disorder but often not optimally treated. High-flow oxygen and parenteral triptans are the most effective treatment to treat an acute CH attack. Transitional treatments include systemic steroid therapy and sub-occipital steroid injection. For preventive therapy, verapamil and lithium are recommended as first-line treatments. Novel treatments have appeared, such as neuromodulation and medication targeting calcitonin gene-related peptide (CGRP) or its receptor. Galcanezumab, the only anti-CGRP receptor monoclonal antibody with proven efficacy for the preventive treatment of episodic CH, represents an important advance for pharmacological treatment of CH. Neuromodulation strategies, such as the non-invasive vagus nerve stimulation and the sphenopalatine ganglion stimulation, have been proven effective in reducing the intensity and frequency of attacks, and also to be safe and well tolerated.
Abstract
Cluster headache (CH) is characterized by severe unilateral short-lasting headache attacks, accompanying ipsilateral cranial autonomic symptoms or the sense of restlessness and agitation, or both. CH is a highly disabling primary headache disorder but often not optimally treated. High-flow oxygen and parenteral triptans are the most effective treatment to treat an acute CH attack. Transitional treatments include systemic steroid therapy and sub-occipital steroid injection. For preventive therapy, verapamil and lithium are recommended as first-line treatments. Novel treatments have appeared, such as neuromodulation and medication targeting calcitonin gene-related peptide (CGRP) or its receptor. Galcanezumab, the only anti-CGRP receptor monoclonal antibody with proven efficacy for the preventive treatment of episodic CH, represents an important advance for pharmacological treatment of CH. Neuromodulation strategies, such as the non-invasive vagus nerve stimulation and the sphenopalatine ganglion stimulation, have been proven effective in reducing the intensity and frequency of attacks, and also to be safe and well tolerated.
참고문헌 (55)
- Katsarava Z, "Prevalence of cluster headache in a population-based sample in Germany", Cephalalgia, 27, pp.1014~1019 (2007)
- Fischera M, "The incidence and prevalence of cluster headache: a meta-analysis of population-based studies", Cephalalgia, 28, pp.614~618 (2008)
- May A, "EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias", Eur J Neurol, 13, pp.1066~1077 (2006)
- Francis GJ, "Acute and preventive pharmacologic treatment of cluster headache", Neurology, 75, pp.463~473 (2010)
- Robbins MS, "Treatment of cluster headache: the American Headache Society evidence-based guidelines", Headache, 56, pp.1093~1106 (2016)
- Brainin M, "Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004", Eur J Neurol, 11, pp.577~581 (2004)
- Calboun AH, "Treatment of cluster headache in pregnancy and lactation", Curr Pain Headache Rep, 14, pp.164~173 (2010)
- Jurgens T, "Treatment of cluster headache in pregnancy and lactation", Cephalalgia, 29, pp.391~400 (2009)
- Stuart MP, "Effectiveness of oxygen and other acute treatments of cluster headache: results from the cluster questionnaire, an international survey", Headache, 59, pp.235~249 (2019)
- Fogan L, "Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation", Arch Neurol, 42, pp.362~363 (1985)
- Cohen AS, "High-flow oxygen for treatment of cluster headache: a randomized trial", JAMA, 302, pp.2451~2457 (2009)
- Todd DR, "Demand valve oxygen: a promising new oxygen delivery system for the acute treatment of cluster headache", Pain Med, 14, pp.455~459 (2013)
- Petersen AS, "Oxygen therapy for cluster headache. A mask comparison trial. A single-blinded, placebo-controlled, crossover study", Cephalalgia, 37, pp.214~224 (2017)
- Backx APM, "Cluster headache and oxygen: is it possible to predict which patients will be relieved? A retrospective cross-sectional correlation study", J Neurol, 257, pp.1533~1542 (2010)
- Group TSCHS, "Treatment of acute cluster headache with sumatriptan", N Engl J Med, 325, pp.322~326 (1991)
- Rapoport AM, "Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study", Neurology, 69, pp.821~826 (2007)
- Bahra A, "Oral zolmitriptan is effective in the acute treatment of cluster headache", Neurology, 54, pp.1832~1839 (2000)
- Lademann V, "Evaluation of guideline-adherent treatment in cluster headache", Cephalalgia, 36, pp.760~764 (2016)
- Giani L, "Cluster headache not responsive to sumatriptan: a retrospective study", Cephalalgia, 41, pp.117~121 (2021)
- Robbins L, "Intranasal lidocaine for cluster headache", Headache, 35, pp.83~84 (1995)
- Costa A, "The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache", Cephalalgia, 20, pp.85~91 (2000)
- Nonis R, "Evidence of activation of vagal afferents by non-invasive vagus nerve stimulation: an electrophysiological study in healthy volunteers", Cephalalgia, 37, pp.1285~1293 (2017)
- Hawkins JL, "Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine", Pain Rep, 2, pp.e628~ (2017)
- Oshinsky ML, "Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia", Pain, 155, pp.1037~1042 (2014)
- Goadsby PJ, "Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study", Cephalalgia, 38, pp.959~969 (2018)
- Silberstein SD, "Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study", Headache, 56, pp.1317~1332 (2016)
- May A, "Cluster headache", Nat Rev Dis Primers, 4, pp.18006~ (2018)
- Schoenen J, "Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study", Cephalalgia, 33, pp.816~830 (2013)
- Jurgens TP, "Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache", Cephalalgia, 37, pp.423~434 (2017)
- Barloese M, "Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry", J Headache Pain, 19, pp.6~ (2018)
- Nesbitt AD, "Cluster headache", BMJ, 11(344), pp.e2407~ (2012)
- May A, "Cluster headache: pathogenesis, diagnosis, and management", Lancet, 366, pp.843~855 (2005)
- Obermann M, "Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial", Lancet Neurol, 20, pp.29~37 (2021)
- Ambrosini A, "Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study", Pain, 118, pp.92~96 (2005)
- Leroux E, "Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial", Lancet Neurol, 10, pp.891~897 (2011)
- Rozen TD, "High-volume anesthetic suboccipital nerve blocks for treatment refractory chronic cluster headache with long-term efficacy data: an observational case series study", Headache, 59, pp.56~62 (2019)
- Lavin PJ, "Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids", Headache, 41, pp.902~904 (2001)
- Sarchielli P, "Italian guidelines for primary headaches: 2012 revised version", J Headache Pain, 13(Suppl 2), pp.S31~S70 (2012)
- Wei J, "Greater occipital nerve injection versus oral steroids for short term prophylaxis of cluster headache: a retrospective comparative study", Headache, 58, pp.852~858 (2018)
- Bussone G, "Double blind comparison of lithium and verapamil in cluster headache prophylaxis", Headache, 30, pp.411~417 (1990)
- Leone M, "Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo", Neurology, 54, pp.1382~1385 (2000)
- Cohen AS, "Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy", Neurology, 69, pp.668~675 (2007)
- Tso AR, "Machine phenotyping of cluster headache and its response to verapamil", Brain, 144, pp.655~664 (2021)
- Steiner TJ, "Double-blind placebo-controlled trial of lithium in episodic cluster headache", Cephalalgia, 17, pp.673~567 (1997)
- Pringsheim T, "Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study", Headache, 42, pp.787~792 (2002)
- Leone M, "Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups", Cephalalgia, 16, pp.494~496 (1996)
- Gaul C, "Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study", JHP, 18, pp.22~ (2017)
- Magis D, "Advances and challenges in neurostimulation for headaches", Lancet Neurol, 11, pp.708~719 (2012)
- Fontaine D, "Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension", J Headache Pain, 11, pp.23~31 (2010)
- Miller S, "Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients", Eur J Neurol, 24, pp.381~390 (2017)
- Fontaine D, "Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: results of an observational prospective study", Cephalalgia, 37, pp.1173~1179 (2017)
- Goadsby PJ, "Trial of galcanezumab in prevention of episodic cluster headache", N Engl J Med, 381, pp.132~141 (2019)
- Dodick DW, "Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: results from 3-month double-blind treatment", Cephalalgia, 40, pp.935~994 (2020)
- Ruscheweyh R, "Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: results from a retrospective case series support individual treatment attempts", Cephalalgia, 40, pp.1574~1584 (2020)
- Kudrow D, "Treatment outcomes in patients treated with galcanezumab vs placebo:post hoc analyses from a phase 3 randomized study in patients with episodic cluster headache", Headache, 60, pp.2254~2264 (2020)
